An Economic Evaluation of Tiludronic Acid Treatment in Paget’s Disease of Bone

The objective of this study was to evaluate the long term comparative outcome of intermittent courses of therapy with low-dosage tiludronic acid (400 mg/day) versus etidronic acid in patients with Paget’s disease of bone.